Downloads

  1. Improved Clearance Of Host Cell Proteins After Virus Inactivation 9/1/2026

    Learn how post-viral inactivation filtration can support precipitate and host cell protein removal while balancing throughput, purity and cost across different feeds and process development conditions.

  2. Controls For Retrieval-Augmented Generation In GxP 9/1/2026

    Validation teams deal with inherent variability all the time. The same principles for GMP — think visual inspection — can apply to probabilistic AI systems.

  3. July 2026 — CDMO Opportunities And Threats Report 9/1/2026

    Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

  4. Using Computational Fluid Dynamics To Design Scalable Processes 8/31/2026

    Learn how CFD modeling and experimental data can be combined to assess power input, mixing, oxygen transfer, and more across bioreactor scales, supporting sound process decisions.

  5. Driving Optimization Through Connected Laboratory Environments 8/31/2026

    Discover how connected laboratory data and predictive modeling can strengthen process control, improve yield, and more, creating a faster and more resource-efficient approach.

  6. ADC CDMO Selection For Small Biotech 8/31/2026

    Manufacturing is a critical factor in ADC success. Discover how to align CDMO capabilities with molecule complexity, mitigate risks, and navigate capacity limits.

  7. Preclinical Genome Editing Risk Assessment Services 8/31/2026

    Regulatory-aligned off-target risk assessment for genome editing programs, from early guide RNA screening through IND-enabling confirmation studies, structured to support FDA submission requirements.

  8. Implementing AI Solutions In GMP While Managing Risk 8/28/2026

    When using artificial intelligence in GMP settings, risk management extends far beyond  validation. This discussion explores moving AI solutions out of the pilot phase.

  9. Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins 8/27/2026

    Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.

  10. Build Process Robustness Through Deeper Process Understanding 8/27/2026

    Compare statistical, mechanistic, and machine learning approaches to understand their principles, requirements, and future potential for improving efficiency and supporting better decisions.